News
7th April 2020

Updated Commitment on COVID-19

Updated Commitment on COVID-19

Cello Health Commitment on COVID-19

We at Cello Health sincerely hope this finds you, your family and friends safe and healthy. We also want to express our sincere gratitude to essential workers and to all those on the front line dealing with this crisis.

With the advent of the COVID-19 crisis, our overriding objective has been to ensure the safety of our employees.  The entire employee base of the Group has been working remotely for a number of weeks now, delivering largely uninterrupted services consistent with our commitment to clients to ensure the continuation of business.  Our people are showing great resilience, creativity and ingenuity in partnering with clients to find new ways to provide continuity of services.  We are proud of our agility and ability to deploy both new and existing digital technologies within the Group to replace all live contact and enable virtual workshops, meetings, and interviews to be carried out to great effect.

We recognize that these are very challenging times for our people and have ensured that all leaders and managers in our business are sensitive to the pressures this crisis can create for anyone working from home, many of whom are now simultaneously handling a different household dynamic with children and possibly essential workers to care for.  Health and well-being is top of mind in relation to ensuring we look after our people whilst delivering services to our clients during this time of great uncertainty.  In this context, we have implemented an augmented ‘modus operandi’ in relation to how we manage, communicate, and provide support services across the Cello Health family during this stressful time.

In support of health system needs in the crisis, our regulatory consultancy practice in the US is preparing a number of submissions to the FDA, known as Emergency Use Authorizations, for the repurposing of facilities or products in the pandemic.  Examples include approval of conversion of a manufacturing facility to make masks and hospital gowns.  Globally, we are also currently working quickly to alter programs that heighten our client’s ability to continue to provide access to crucial new treatments and support in areas such as oncology and multiple sclerosis.

In the UK, we are proud to be supporting the Scottish Government in the creation of a series of compelling public health campaigns to drive social distancing and self-isolation as well as heightened community spirit and protection of the most vulnerable in our society.  We are also working with the European Federation of Pharmaceutical Industries (EFPIA) to support their activities as they focus on providing world-leading science and resources to tackle the COVID-19 outbreak.

Our business continuity framework prepared us well for the changes necessitated over the past several weeks.  Our business continuity team continues to carefully monitor the development of the COVID-19 outbreak and we will continue to adjust as need be to meet our commitments to employee well-being and client business continuity.  In addition, we continue to monitor all advice and guidance issued by States or local authorities, and the Centers for Disease Control and Prevention (CDC) and World Health Organization.

If you have any immediate questions or require any further information, please contact your Client Account contact in the first instance

Related Articles

Arsenal Capital Partners Completes £182 million Acquisition of Cello Health
11 August 2020
Arsenal Capital Partners Completes £182 million Acquisition of Cello Health

The acquisition of Cello Health provides the foundation for a new enterprise to enable healthcare and biopharmaceutical clients to maximize the value of their products.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us